Trials / Recruiting
RecruitingNCT06578702
Evaluation of Intermittent Triple Therapies in Real Life
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The strategy of intermittent triple therapy for people living with HIV was validated in France following the randomized clinical trial QUATUOR. There is little data in real life, as shown in the meta-analysis of Parienti JJ et al. Currently this strategy is proposed by some teams in France, but is not recommended internationally. The research hypothesis is that intermittent treatment is an effective and safe option in a therapeutic lightening strategy in people living with HIV People living with HIV adults followed in Strasbourg who have benefited from intermittent treatment The expected results will consist of an improvement in knowledge on the efficacy and tolerance of this therapeutic strategy.
Conditions
Timeline
- Start date
- 2024-02-21
- Primary completion
- 2025-02-01
- Completion
- 2025-02-21
- First posted
- 2024-08-29
- Last updated
- 2024-08-29
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06578702. Inclusion in this directory is not an endorsement.